Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia

BACKGROUND: Two programs to reduce expenditures for common gastrointestinal drugs were introduced simultaneously by British Columbia (BC) Pharmacare in 1995. Reference-based pricing restricted reimbursement for all histamine-2 receptor antagonists (H(2)RAs) to the cost of the least expensive H(2)RA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Marshall, John K., Grootendorst, Paul V., O'Brien, Bernie J., Dolovich, Lisa R., Holbrook, Anne M., Levy, Adrian R.
Formato: Artigo
Idioma:Inglês
Publicado: 2002
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC116151/
https://ncbi.nlm.nih.gov/pubmed/12126319
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares